(Q37389895)

English

Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.

scientific article published on June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02. (English)

1 reference

Europe PubMed Central

20 August 2017

radiation therapy

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Li Yan Khor

1

1 reference

Europe PubMed Central

20 August 2017

Jennifer Moughan

2

1 reference

Europe PubMed Central

20 August 2017

Tahseen Al-Saleem

3

1 reference

Europe PubMed Central

20 August 2017

Elizabeth H Hammond

4

1 reference

Europe PubMed Central

20 August 2017

Varagur Venkatesan

5

1 reference

Europe PubMed Central

20 August 2017

Seth A Rosenthal

6

1 reference

Europe PubMed Central

20 August 2017

Mark A Ritter

7

1 reference

Europe PubMed Central

20 August 2017

Howard M Sandler

8

1 reference

Europe PubMed Central

20 August 2017

Gerald E Hanks

9

1 reference

Europe PubMed Central

20 August 2017

William U Shipley

10

1 reference

Europe PubMed Central

20 August 2017

Alan Pollack

11

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 June 2007

1 reference

Europe PubMed Central

20 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

20 August 2017

13

1 reference

Europe PubMed Central

20 August 2017

3585-3590

1 reference

Europe PubMed Central

20 August 2017

12

1 reference

Europe PubMed Central

20 August 2017

Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Androgen and its receptor promote Bax-mediated apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Antisense Bcl-2 sensitizes prostate cancer cells to radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Immunohistochemical expression of Bax and Bcl-2 in penile carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Apoptosis and bcl-2 expression in prostate cancer: significance in clinical outcome after brachytherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

6 September 2017

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

14 September 2017

Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

14 September 2017

Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

28 September 2017

Molecular correlates of bcl-2-enhanced growth following androgen-ablation in prostate carcinoma cells in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

28 September 2017

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

26 June 2018

Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

2 September 2018

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

2 September 2018

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763095

2 September 2018

Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis, mitosis, p53, bcl(2), Ki-67 and clinical outcome in prostate carcinoma treated by androgen ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of Ki-67 antigen and Bcl-2 protein expression in prostate cancer: effect of neoadjuvant hormonal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17575222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-06-2972

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37389895&oldid=1564747546"